FDA to use enforcement discretion on whole-grains health claims

The FDA says there is limited evidence to support health claims that whole-grain consumption can reduce diabetes risk, and that it will use its enforcement discretion for two food-label claims that whole grains may reduce the risk of type 2 diabetes. Food manufacturers are permitted to make the claims if they are worded in a manner that does not mislead consumers.

View Full Article in:

FoodBusinessNews.net (free registration) · CandyAndSnackToday.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Chief, Product Review Branch
FDA/Center for Biologics Evaluation and Research
Silver Spring, MD
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ
FDA Attorney
Axinn
Washington, DC